272 related articles for article (PubMed ID: 32498415)
1. Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.
Bongomin F; Asio LG; Baluku JB; Kwizera R; Denning DW
J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32498415
[TBL] [Abstract][Full Text] [Related]
2. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Denning DW; Cadranel J; Beigelman-Aubry C; Ader F; Chakrabarti A; Blot S; Ullmann AJ; Dimopoulos G; Lange C;
Eur Respir J; 2016 Jan; 47(1):45-68. PubMed ID: 26699723
[TBL] [Abstract][Full Text] [Related]
3. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.
Evans TJ; Lawal A; Kosmidis C; Denning DW
Semin Respir Crit Care Med; 2024 Feb; 45(1):88-101. PubMed ID: 38154471
[TBL] [Abstract][Full Text] [Related]
4. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
5. Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary care center in Uganda: a case series.
Kwizera R; Katende A; Bongomin F; Nakiyingi L; Kirenga BJ
J Med Case Rep; 2021 Mar; 15(1):140. PubMed ID: 33781313
[TBL] [Abstract][Full Text] [Related]
6. The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach.
Maghrabi F; Denning DW
Curr Fungal Infect Rep; 2017; 11(4):242-251. PubMed ID: 29213345
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
8. Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis.
Mei ZX; Han JF; Yu HW; Zhang Y; Ji P; Xie Y; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1081-1089. PubMed ID: 37453946
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Laboratory Features and Performance of an
Zhu RS; Zhou LH; Cheng JH; Luo Y; Qiu WJ; Huang JT; Jiang YK; Zhao HZ; Wang X; Chen ZQ; Zhu LP
Microbiol Spectr; 2023 Jun; 11(3):e0026423. PubMed ID: 37125929
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil.
Volpe-Chaves CE; Venturini J; B Castilho S; S O Fonseca S; F Nunes T; T Cunha EA; M E Lima G; O Nunes M; P Vicentini A; V L Oliveira SM; Carvalho LR; Thompson L; P Mendes R; M M Paniago A
Mycoses; 2022 Jul; 65(7):715-723. PubMed ID: 35524507
[TBL] [Abstract][Full Text] [Related]
11. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
12. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
[TBL] [Abstract][Full Text] [Related]
13. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
[TBL] [Abstract][Full Text] [Related]
14. Chronic pulmonary aspergillosis.
Schweer KE; Bangard C; Hekmat K; Cornely OA
Mycoses; 2014 May; 57(5):257-70. PubMed ID: 24299422
[TBL] [Abstract][Full Text] [Related]
15. Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
Moazam S; Eades CP; Muldoon EG; Moore CB; Richardson MD; Rautemaa-Richardson R
Mycoses; 2020 Apr; 63(4):376-381. PubMed ID: 31981256
[TBL] [Abstract][Full Text] [Related]
16. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre.
Osborne W; Fernandes M; Brooks S; Grist E; Sayer C; Hansell DM; Wilson R; Shah A; Loebinger MR
Clin Respir J; 2020 Jun; 14(6):571-577. PubMed ID: 32077238
[TBL] [Abstract][Full Text] [Related]
17. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
Sehgal IS; Dhooria S; Prasad KT; Muthu V; Aggarwal AN; Chakrabarti A; Agarwal R
Mycoses; 2021 Sep; 64(9):1053-1061. PubMed ID: 34031920
[TBL] [Abstract][Full Text] [Related]
18. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Bongomin F; Harris C; Hayes G; Kosmidis C; Denning DW
PLoS One; 2018; 13(4):e0193732. PubMed ID: 29634721
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Saito T; Fujiuchi S; Tao Y; Sasaki Y; Ogawa K; Suzuki K; Tada A; Kuba M; Kato T; Kawabata M; Kurashima A; Sakatani M;
Infection; 2012 Dec; 40(6):661-7. PubMed ID: 22956473
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
